Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol versus oxycodone for moderate to severe pain after orthopedic surgery
ChiCTR2300069799Phase 3Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tapentadol and oxycodone in postoperative pain (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: NRS pain intensity score. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
tapentadoloxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300069799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069799.